Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
Female infertility is a multifaceted challenge, with key causes ranging from ovulatory disorders and tubal factors to lifestyle and environmental influences. This quick reference guide outlines the primary causes of infertility in women, providing clinicians with a clear understanding to aid in diagnosis and initial management. By recognizing these core contributors and adopting an evidence-based approach, healthcare providers can make informed decisions and determine when specialist referral is essential for optimizing patient outcomes.
| Category | Description | Examples |
|---|---|---|
| Ovulatory Disorders | Conditions affecting the release of eggs from the ovaries, responsible for ~25-40% of infertility cases. |
- Polycystic Ovary Syndrome (PCOS) - Hypothalamic Dysfunction (due to stress, weight changes, etc.) - Premature Ovarian Insufficiency (POI) - Hyperprolactinemia (high prolactin levels) |
| Tubal Factors | Blockage or damage to the fallopian tubes, preventing sperm and egg from meeting, accounts for ~15-20% of cases. |
- Pelvic Inflammatory Disease (PID) - Previous surgeries causing adhesions - Congenital tubal abnormalities |
| Endometriosis | Growth of endometrial-like tissue outside the uterus, causing inflammation, adhesions, and anatomical distortions. |
- Pelvic adhesions - Tubal blockages - Ovulatory dysfunction due to endometrial lesions |
| Uterine and Cervical Factors | Issues with the structure or function of the uterus or cervix that interfere with sperm passage or implantation. |
- Uterine fibroids - Congenital uterine anomalies (e.g., septate or bicornuate uterus) - Cervical stenosis - Poor cervical mucus quality |
| Other Medical and Endocrine Conditions | Systemic conditions that disrupt reproductive hormones and cycles. |
- Thyroid disorders (e.g., hypothyroidism, hyperthyroidism) - Diabetes - Autoimmune disorders (e.g., lupus) |
| Genetic or Chromosomal Abnormalities | Certain genetic conditions that impact egg production, hormone levels, or reproductive anatomy. |
- Turner Syndrome (45,X) - Fragile X Premutation - Kallmann Syndrome (a rare genetic condition causing hypothalamic dysfunction) |
| Unexplained Infertility | Cases where no clear cause is identified after thorough evaluation, ~10-20% of infertility cases. | - May involve subtle issues such as mild hormonal imbalances or immune factors |
| Lifestyle and Environmental Factors | External factors affecting fertility, often related to overall health and lifestyle. |
- Age (fertility declines after age 35) - Weight (significantly underweight or overweight) - Substance use (e.g., smoking, alcohol) - Exposure to environmental toxins |
Ovulatory disorders account for approximately 25% of infertility cases, with conditions such as Polycystic Ovary Syndrome (PCOS) being prevalent . Tubal factors, often resulting from pelvic inflammatory disease or previous surgeries, can also significantly impact fertility . Understanding these causes allows clinicians to tailor their approach to each patient effectively.
Thorough Evaluation is Key: A comprehensive assessment, including medical history, physical examination, and diagnostic tests, is essential for identifying the underlying causes of infertility. Hormonal assessments and imaging studies are critical components of this process.
Targeted Management Based on Cause: Management should be tailored to the specific diagnosis. Ovulatory disorders may benefit from lifestyle changes and medications, while tubal factor infertility may require surgical intervention or assisted reproductive technologies (ART).
Importance of Specialist Referral: Timely referral to a fertility specialist or reproductive endocrinologist is essential, especially for cases requiring advanced interventions. Collaboration with specialists ensures patients receive the most appropriate care for complex infertility issues.
Evidence-Based Approach: Staying updated on the latest evidence-based guidelines enables primary care clinicians to provide optimal initial care and recognize when specialist input is necessary.
1. **Abebe, M., Afework, M., & Abaynew, Y.** (2020). Primary and secondary infertility in Africa: systematic review with meta-analysis. *Fertility Research and Practice, 6*(1). [https://doi.org/10.1186/s40738-020-00090-3](https://doi.org/10.1186/s40738-020-00090-3)
2. **AbrĂŁo, M., Muzii, L., & Marana, R.** (2013). Anatomical causes of female infertility and their management. *International Journal of Gynecology & Obstetrics, 123*(S2). [https://doi.org/10.1016/j.ijgo.2013.09.008](https://doi.org/10.1016/j.ijgo.2013.09.008)
3. **Boltz, M., Sanders, J., Simonsen, S., & Stanford, J.** (2017). Fertility treatment, use of in vitro fertilization, and time to live birth based on initial provider type. *The Journal of the American Board of Family Medicine, 30*(2), 230-238. [https://doi.org/10.3122/jabfm.2017.02.160184](https://doi.org/10.3122/jabfm.2017.02.160184)
4. **Dhananjaya, S., Madhu, K., & Amiti, A.** (2014). Role of diagnostic hysterolaparoscopy in evaluation of primary and secondary infertility. *Journal of Evolution of Medical and Dental Sciences, 3*(9), 2194-2207. [https://doi.org/10.14260/jemds/2014/2126](https://doi.org/10.14260/jemds/2014/2126)
5. **Hinton, L., Kurinczuk, J., & Ziebland, S.** (2012). Reassured or fobbed off? Perspectives on infertility consultations in primary care: a qualitative study. *British Journal of General Practice, 62*(599), e438-e445. [https://doi.org/10.3399/bjgp12x649133](https://doi.org/10.3399/bjgp12x649133)
6. **Kabadi, Y., & Harsha, B.** (2016). Hysterolaparoscopy in the evaluation and management of female infertility. *The Journal of Obstetrics and Gynecology of India, 66*(S1), 478-481. [https://doi.org/10.1007/s13224-016-0863-5](https://doi.org/10.1007/s13224-016-0863-5)
7. **Khanuja, P., Sunny, J., & Pawar, S.** (2017). Study on infertility—etiology, medication therapy management, and outcomes at a tertiary care hospital. *International Journal of Infertility & Fetal Medicine, 8*(3), 106-112. [https://doi.org/10.5005/jp-journals-10016-1158](https://doi.org/10.5005/jp-journals-10016-1158)
8. **Madhuri, N., Rashmi, H., Sujatha, M., & Dhanyata, G.** (2019). Role of diagnostic hysterolaparoscopy in the evaluation of female infertility. *International Journal of Research in Medical Sciences, 7*(5), 1531. [https://doi.org/10.18203/2320-6012.ijrms20191630](https://doi.org/10.18203/2320-6012.ijrms20191630)
9. **Nida, .., Qureshi, M., Usman, H., Akram, A., Khan, S., Jawad, N., … & Bhutta, M.** (2022). A cross-sectional study on serum follicle stimulating hormone and luteinizing hormone in patients with anovulatory disorders with primary infertility. *PJMHS, 16*(12), 490-492. [https://doi.org/10.53350/pjmhs20221612490](https://doi.org/10.53350/pjmhs20221612490)
10. **Nour-Eldein, H.** (2013). Family physicians’ attitude and practice of infertility management at primary care - Suez Canal University, Egypt. *Pan African Medical Journal, 15*. [https://doi.org/10.11604/pamj.2013.15.106.1762](https://doi.org/10.11604/pamj.2013.15.106.1762)
11. **Palmer-Wackerly, A., Voorhees, H., D'Souza, S., & Weeks, E.** (2019). Infertility patient-provider communication and (dis)continuity of care: an exploration of illness identity transitions. *Patient Education and Counseling, 102*(4), 804-809. [https://doi.org/10.1016/j.pec.2018.12.003](https://doi.org/10.1016/j.pec.2018.12.003)
12. **Stanford, J., Carpentier, P., Meier, B., Rollo, M., & Tingey, B.** (2021). Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study. *BMC Pregnancy and Childbirth, 21*(1). [https://doi.org/10.1186/s12884-021-03946-8](https://doi.org/10.1186/s12884-021-03946-8)
13. **Verma, K., & Baniya, G.** (2016). A comparative study of depression among infertile and fertile women. *International Journal of Research in Medical Sciences*, 3459-3465. [https://doi.org/10.18203/2320-6012.ijrms20162312](https://doi.org/10.18203/2320-6012.ijrms20162312)
